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MEN 2A: Update on the Northern Ireland and Australian FamDy
Patrick J. Morrison,* David R. Hadden,* Colin J. Russell,* and Norman C. Nevin*

The Northern Irelandl Australian family with mulliple endocrine neoplasia lype 2A (MEN 2A)
originally described in 1987 is presented with a revised and enlarged pedigree. Four members of the
first generation studied have died. A seventh member of the second generation studied has developed
medullary thyroid carcinoma and has progressed to surgery. None oflhe third generation members
studied has shown any conclusive abnormality in metabolic screening lests. Each member of the third
and fourth generations has had genetic counseling and (if appropriate) DNA analysis wilh gene
probes close lo the MEN 2A gene locus on chromosome 10. All members ofthis highly penetrant family
have remained asymptomatic for their disease. (Henry Ford Hosp Med J 1989:37:127-8)

M

edullary thyroid carcinoma (MTC) in association with
pheochromocytoma was originally described by Sipple (1)
with the hereditary nature being recognized by Cushman (2).
Since the first two workshops on multiple endocrine neoplasia type 2 (MEN 2) in 1984 and 1986, the gene for MEN 2A
has been localized to chromosome 10. Alt reports of MEN 2A
show autosomal dominant inheritance with a high degree of
penetrance.
The G-kindred, originally described in 1987 (3), have been
living in County Antrim, Northem Ireland, for many generations. Several members emigrated to Australia in their youth,
producing three Austratian branches of the pedigree. Initiat
screening using basal unstimulated plasma calcitonin (CT) and
24-hour urinary catecholamines, followed by adrenal computed
tomography and '"1 meta-iodo-benzylguanidine imaging produced positive resutts in some members of the famity. We have
updated these resutts and have used both pentagastrin stimulation CT tests and DNA gene probe anatysis to obtain further information in patients whose initially described tests were either
uninformative or inappropriate. The updated pedigree is shown
in the Figure.

Updated Case Reports
Patients' ages reported are as of 1988.
Case 1-3; This patient, initially thought to be deceased, was
discovered to be alive and healthy at age 88. She remains
clinically euthyroid and asymptomatic. Blood has been taken
for DNA anatysis.
Case II-1; This patient, the index case, died in 1972. We hope
to use histologic tissue for D N A extraction to aid pedigree
anatysis.
Cases II-2 and II-6; Both remain welt after thyroid surgery.
Blood has been taken for DNA analysis.
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Cases II-3, II-4, II-5; These three Australian brothers alt died
of MTC,
Case II-7; This member is apparently asymptomatic and has
refused metabolic and genetic screening. The thyroid gland was
not palpable.
Cases I l l - t , i n - 2 , m - 4 , nt-5,111-12; A f i remain cfinicalty
asymptomatic. CT basal levels remain unchanged. Blood has
been taken for DNA anatysis.
Cases III-3, III-6, III-8, Ill-tO, I l l - I t , U M 4 ; Att are welt fotlowing surgery for MTC. Blood has been taken for DNA anatysis, but atl have refused pentagastrin tests.
Case III-9; This member is clinically asymptomatic. Pentagastrin tests using the intravenous technique as described by
Telenius-Berg et at (4) resulted in undetectable CT before and
after stimulation.
Case 111-13; This member is clinically asymptomatic. Pen<0.02 p-g/L basal and
0.03 |JLg/L at two minutes. Blood has been taken for DNA
analysis.
Case 111-15; This member is clinically asymptomatic. Pentagastrin test resutts show CT levels of 0.02 p,g/L basal and 0.03
fjLg/L at two minutes. Blood has been taken for DNA analysis.
Case III-7; This 25-year-old man has a barely palpable thyroid gland and no clinical symptoms. Inifial basal plasma CT
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Figure—Updated pedigree of G-kindred.

was 0,71 p-g/L; CT remained etevated on subsequent measurements. Although he was initially unwitting to have thyroid surgery, total thyroidectomy done in 1988 showed multiple smalt
foci of MTC, several C-cell adenomas, and a large parathyroid
adenoma within the right lobe of the gland. He remains well
with normal calcium and CT tevels postoperatively. Computed
tomography of the adrenals has shown bilateral nodules consistent with pheochromocytomas. Plasma and urinary catecholamines remain normal. Adrenal surgery is cunentiy under
consideration. Blood has been taken for DNA analysis.
Cases IV-5 and IV-6; Blood has been taken for DNA anatysis.
Basal CT levels are marginally elevated.
Remainder of generation IV cases; Basal CT levels remain
unchanged. Atl members under 18 years of age have been
screened only for basal CT levels. Pentagastrin testing has not
been attempted, and blood has not been taken for DNA analysis.

screening for their own diagnosis, permission has been obtained
for the results to be used to help other members of the pedigree.
Since the ethical guidelines for screening patients under age
18 are uncertain, we have not taken blood for DNA from most
patients in generation IV; only two patients were studied with
their parents' consent. This approach may change with either
clinical concem or from changes in guidelines regarding screening of minors.
Some patients have declined pentagastrin testing but consented to DNA testing. The rationale is that pentagastrin testing
is "invasive," ie, it involves injection of a foreign substance
with uncomfortable but limited side effects, whereas gene testing is neither physically harmful nor invasive.
Easton et al (5) have suggested that there is an earlier onset of
MTC in females and a tendency for pheochromocytoma to cluster in families. Our pedigree does not support the first hypothesis; most of our family members presented at about the same
age. The pedigree does, however, show clustering of pheochromocytomas in two branches. The pedigree in general shows
that the gene is highly penetrant in character but with a variable
expressivity; no individuals diagnosed with MTC have shown
symptoms.
We still do not know in whom the mutant gene originated.
Patient I-1 was reputed to have a sister who died having had "thyroid trouble." Current genetic tracing using the RBP3, MCK2,
and plO alpha centromere probes may help either to confine or
broaden the existing pedigree.
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Discussion
Between 1965 and 1986, 25 cases of MTC were diagnosed
histologically in Northem Ireland. Seven of these are from the
G-kindred. The remainder have not yet shown any hereditary
tendency.
Although we attempted to bring family members together for
same-day counseling and screening, we leamed that this was inappropriate and inadvisable because of various family member
interactions and the reasonable desire for personal discussion.
Each member has subsequentiy been seen by one of us (PJM) on
a one-to-one basis, usually in the patient's home. This has allowed the patients to discuss their problems and fear of the disease and has allowed DNA sampling from virtually all the patients over age 18. If the patients do not allow counseling and
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